Arquivamento definitivo - Art. 33 da LPI
#11.1.1
06/13/2023
RPI 2736
Application data
Number
112021011699Type
Filing
Publication
PCT
IB2019060987 The application was abandoned: examination was not requested within the 36 months following the 12/18/2019 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 06/13/2023. We update with every new RPI gazette, published weekly.
Applicants
NOVARTIS AG
CH
Inventors
G. C. (pessoa física)
US
IPC Classification
Priority claims
US
62/782,767 · 12/20/2018
US
62/793,128 · 01/16/2019
Abstract
TERAPIA DE COMBINAÇÃO COM UM INIBIDOR DE RAF E UM INIBIDOR DE CDK4/6 PARA USO NO TRATAMENTO CONTRA CÂNCER.A presente invenção refere-se a uma combinação farmacêutica que compreende (a) um inibidor de Raf, conforme definido no pre-sente documento, ou um sal farmaceuticamente aceitável do mesmo, e (b) um inibidor de CKD4/6, particularmente, ribociclib, particularmente, para uso no tratamento contra uma doença proliferativa, de preferência melanoma ou adenocarcinoma ductal pancreático.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
06/13/2023
RPI 2736
#11.1
03/28/2023
RPI 2725
#1.3
09/08/2021
RPI 2644
#1.1
06/29/2021
RPI 2634
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.